Ross Systems Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (31)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
Article By: ChinaBio® Today
Saturday, January 21, 2023 3:51 PM EDT
Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in milestones, plus single digit royalties on sales.
In this article: IRON Also: SDGR, ROSS, GNNSF
Read
Some Bullish Moves Worth Mentioning In A Bearish Market
Article By: Brad Thomas
Tuesday, May 24, 2022 1:45 PM EDT
May has been another anemic month for every equity index, from the Nasdaq to the Dow. As a few too many Q1 earnings reports miss their marks, each day seems to bring more uncertainty. As the tickers slant down, many wonder where the bottom will be.
In this article: CAT, DE, JPM, SBUX, ROSS, ILPT, OPI, DHC, SVC
Read
All Posts

Latest Tweets for $ROSS

No tweets yet!

PARTNER HEADLINES